Literature DB >> 1385546

Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes.

A P van den Berg1, W J van Son, R A Janssen, N H Brons, A A Heyn, A Scholten-Sampson, S Postma, M van der Giessen, A M Tegzess, L H de Leij.   

Abstract

The number of CD8bright and CD56+ lymphocytes in the peripheral blood and their activation status were monitored by flow cytometry in 23 renal transplant recipients with cytomegalovirus (CMV) infection and were correlated with the virus load (as determined by CMV antigenemia) and clinical symptoms. Recovery from CMV infection coincided with expansion of the CD8bright and CD56+ subsets and with increased expression of the activation marker HLA-DR. Primary infection was associated with activation of both subsets, whereas during secondary infection, mainly CD8bright cells responded. Progressive CMV disease (requiring antiviral treatment) and relapse occurred in association with low numbers of activated CD8bright and CD56+ cells. Lymphocyte activation and antibody responses against CMV often occurred simultaneously, but different kinetics of these responses in some patients indicated that cellular responses are necessary to control viral replication, whereas humoral responses alone may be insufficient. Monitoring of lymphocyte activation may provide clinically useful information during CMV infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385546     DOI: 10.1093/infdis/166.6.1228

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain.

Authors:  Mao Li; Srinivasa Rao Boddeda; Bo Chen; Qiang Zeng; Trenton R Schoeb; Victoria M Velazquez; Masako Shimamura
Journal:  Am J Transplant       Date:  2018-05-07       Impact factor: 8.086

2.  CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells.

Authors:  M Labalette; F Salez; F R Pruvot; C Noel; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

3.  Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects.

Authors:  Mazen Almehmadi; Brian F Flanagan; Naeem Khan; Suliman Alomar; Stephen E Christmas
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

5.  Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection.

Authors:  I Nordøy; F Müller; K P Nordal; H Rollag; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

6.  Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection.

Authors:  A Caruso; S Licenziati; A D Canaris; A Cantalamessa; S Fiorentini; S Ausenda; D Ricotta; F Dima; F Malacarne; A Balsari; A Turano
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

Authors:  R D Schrier; W R Freeman; C A Wiley; J A McCutchan
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.

Authors:  G Gerna; F Baldanti; A Sarasini; M Furione; E Percivalle; M G Revello; D Zipeto; D Zella
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Authors:  Bradley J Gardiner; Natalie E Nierenberg; Jennifer K Chow; Robin Ruthazer; David M Kent; David R Snydman
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

10.  Inflammatory responses to infection: the Dutch contribution.

Authors:  Martijn A Nolte; Jos W M van der Meer
Journal:  Immunol Lett       Date:  2014-10-18       Impact factor: 3.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.